International Conference on Head and Neck Oncology (ICHNO - 26)

This track will explore the latest discoveries in basic science related to head and neck oncology, focusing on the identification and validation of biomarkers. Participants will discuss how these advancements can inform clinical practice and improve patient outcomes.

This session will delve into novel chemotherapy regimens and the integration of chemo-radiotherapy in the treatment of head and neck cancers. Experts will share insights on optimizing treatment protocols to enhance efficacy and minimize toxicity.

This track will focus on the design, implementation, and outcomes of clinical trials specific to head and neck oncology. Discussions will include challenges faced in recruitment, methodology, and the translation of trial results into clinical practice.

Participants will examine the economic aspects of head and neck cancer treatment, including cost-effectiveness analyses and resource allocation strategies. This track aims to highlight the importance of integrating health economics into clinical decision-making.

This session will address the epidemiology, pathogenesis, and clinical implications of HPV-related head and neck cancers. Experts will discuss screening, prevention strategies, and the impact of HPV status on treatment outcomes.

This track will focus on innovative surgical techniques and reconstructive strategies for patients with head and neck cancers. Participants will share experiences and outcomes related to complex surgical interventions and their impact on quality of life.

This session will explore the assessment of quality of life and patient-centered outcomes in individuals diagnosed with head and neck cancers. Discussions will include methodologies for measuring outcomes and the importance of incorporating patient perspectives into care.

This track will cover the latest advancements in radiotherapy techniques for head and neck cancers, including intensity-modulated radiation therapy and stereotactic body radiotherapy. Participants will discuss the implications of these technologies on treatment efficacy and patient safety.

This session will examine the role of ethnography in understanding the cultural and social dimensions of head and neck cancer care. Participants will discuss how ethnographic research can inform practice and improve health disparities among diverse populations.

This track will focus on the unique challenges associated with the diagnosis and management of skin cancer and melanoma in the head and neck region. Experts will discuss treatment options, surgical considerations, and the importance of early detection.

This session will explore rehabilitation approaches for improving function and quality of life in head and neck cancer survivors. Discussions will include speech therapy, nutritional support, and psychosocial interventions to enhance recovery.